Ismail Sufyan 4
4 · Nemaura Medical Inc. · Filed Jun 7, 2018
Insider Transaction Report
Form 4
Ismail Sufyan
10% Owner
Transactions
- Other
Common Stock
2018-06-05+22,705,000→ 22,705,250 total - Conversion
Series A Convertible Preferred Stock
2018-06-05−22,705→ 0 totalExercise: $0.00→ Common Stock, par value $0.01 (22,705,000 underlying)
Footnotes (3)
- [F1]The Reporting Person converted all of his shares of Series A Convertible Preferred Stock into Common Stock, whereby each share of Series A Convertible Preferred was converted into 1,000 shares of Common Stock.
- [F2]The Reporting Person can automatically convert after all of the following events occur:(a) the sugarBEAT(R) device to be commercialized has CE regulatory approval; (b) retail sales have The Reporting Person can automatically convert after all of the following events occur:(a) the sugarBEAT(R) device to be commercialized has CE regulatory approval; (b) retail sales have commenced; and (c) retail sales exceed USD$5 million, which includes any advanced sales (the "Triggering Events"); the disinterested members of the Board shall confirm the satisfaction of all Triggering Events by written notice to the Corporation's transfer agent. The Reporting Person can voluntarily convert any shares of Series A Preferred then outstanding into fully paid and nonassessable shares of Common Stock.
- [F3]The conversion rights do not expire.